Crossmark

Caplacizumab en debut agudo refractario a tratamiento estándar de púrpura trombocitopénica trombótica

Crossref DOI link: https://doi.org/10.1016/j.farma.2025.01.006

Published Print: 2025-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Reyes-de-la-Mata, Yeray

Cano-Martínez, Gala

Salmerón-Navas, Francisco Javier

Domínguez-Santana, Carmen María

Fenix-Caballero, Silvia
License Information

Text and Data Mining valid from 2025-11-01

Text and Data Mining valid from 2025-11-01

Version of Record valid from 2025-01-28
More Information

This article is maintained by: Elsevier

Article Title: Caplacizumab en debut agudo refractario a tratamiento estándar de púrpura trombocitopénica trombótica

Journal Title: Farmacia Hospitalaria

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.farma.2025.01.006

Content Type: article

Copyright: © 2025 The Author(s). Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Farmacia Hospitalaria (S.E.F.H).